Differentiating aggressive vs. non-aggressive prostate cancer: the MiCheck GPC1 biomarker test

The addition of a new prostate cancer diagnostic test to inform clinicians and patients prior to the decision to biopsy would be beneficial, in conjunction with the traditional measures of PSA and DRE... Author: VJOncology Added: 02/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts